Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs

Colorectal Disease

Volumn 15, Issue 9, 2013, Pages 1115-1122

  Coscia, M ^a   Gentilini, L ^a   Laureti, S ^a   Gionchetti, P ^a   Rizzello, F ^a   Campieri, M ^a   Calabrese, C ^a   Poggioli, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anorectal involvement; Biological drugs; Crohn's colitis; Ileorectal anastomosis; Permanent ileostomy

Indexed keywords

ADALIMUMAB; BIOLOGICAL PRODUCT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB;

ADULT; AGED; ANORECTAL DISEASE; ANORECTAL STENOSIS; ANUS DISEASE; ANUS FISTULA; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURGERY; COLON CROHN DISEASE; COLON RESECTION; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; ILEORECTAL ANASTOMOSIS; ILEOSTOMY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN PRESERVATION; PRIORITY JOURNAL; PROCTITIS; PROCTOCOLECTOMY; RECTUM RESECTION; REMISSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; STOMA; SYSTEMIC THERAPY;

ANORECTAL INVOLVEMENT; BIOLOGICAL DRUGS; CROHN'S COLITIS; ILEORECTAL ANASTOMOSIS; PERMANENT ILEOSTOMY;

ADOLESCENT; ADULT; AGED; ANASTOMOSIS, SURGICAL; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; COLECTOMY; COLITIS; COMBINED MODALITY THERAPY; CROHN DISEASE; FEMALE; HUMANS; ILEOSTOMY; ILEUM; MALE; MIDDLE AGED; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL STOMAS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884722167     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12249     Document Type: Article

References (29)

1. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. JAMA 1932; 99: 1323-9.
2. Schwartz DA, Loftus EV Jr, Tremaine WJ et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-80.
3. Van Dongen LM, Lubbers EJ. Perianal fistulas in patients with Crohn's disease. Arch Surg 1986; 121: 1187-90.
4. Mueller MH, Geis M, Glatzle J et al. Risk of fecal diversion in complicated perianal Crohn's disease. J Gastrointest Surg 2007; 11: 529-37.
5. Galandiuk S, Kimberling J, Al-Mishlab TG et al. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg 2005; 241: 796-801; discussion 801-2.
6. Tekkis PP, Purkayastha S, Lanitis S et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta-analysis. Colorectal Dis 2006; 8: 82-90.
7. Strong SA, Koltun WA, Hyman NH et al. Practice parameters for the surgical management of Crohn's disease. Dis Colon Rectum 2007; 50: 1735-46.
8. Martel P, Betton PO, Gallot D et al. Crohn's colitis: experience with segmental resections; results in a series of 84 patients. J Am Coll Surg 2002; 194: 448-53.
9. Lee E. Split ileostomy in the treatment of Crohn's disease of the colon. Ann R Coll Surg Engl 1975; 56: 94-102.
10. Grant DR, Cohen Z, McLeod RS. Loop ileostomy for anorectal Crohn's disease. Can J Surg 1986; 29: 32-5.
11. Guillem JG, Roberts PL, Murray JJ et al. Factors predictive of persistent or recurrent Crohn's disease in excluded rectal segments. Dis Colon Rectum 1992; 35: 768-72.
12. Sandborn WJ, Fazio VW, Feagan BG et al. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125: 1508-30.
13. Yamamoto T, Keighley MR. Fate of the rectum and ileal recurrence rates after total colectomy for Crohn's disease. World J Surg 2000; 24: 125-9.
14. Cattan P, Bonhomme N, Panis Y et al. Fate of the rectum in patients undergoing total colectomy for Crohn's disease. Br J Surg 2002; 89: 454-9.
15. Poggioli G, Laureti S, Pierangeli F et al. Local injection of infliximab for the treatment of perianal Crohn's disease. Dis Colon Rectum 2005; 48: 768-74.
16. Hyder SA, Travis SP, Jewell DP et al. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49: 1837-41.
17. Taxonera C, Schwartz DA, García-Olmo D. Emerging treatments for complex perianal fistula in Crohn's disease. World J Gastroenterol 2009; 15: 4263-72.
18. Dignass A, Van Assche G, Lindsay JO et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010; 4: 28-62.
19. Van Assche G, Dignass A, Reinisch W et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010; 4: 63-101.
20. Yamamoto T, Keighley MR. Proctocolectomy is associated with a higher complication rate but carries a lower recurrence rate than total colectomy and ileorectal anastomosis in Crohn colitis. Scand J Gastroenterol 1999; 34: 1212-15.
21. Pastore RL, Wolff BG, Hodge D. Total abdominal colectomy and ileorectal anastomosis for inflammatory bowel disease. Dis Colon Rectum 1997; 40: 1455-64.
22. Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum 2001; 44: 647-54; discussion 654.
23. Longo WE, Oakley JR, Lavery IC et al. Outcome of ileorectal anastomosis for Crohn's colitis. Dis Colon Rectum 1992; 35: 1066-71.
24. O'Riordan JM, O'Connor BI, Huang H et al. Long-term outcome of colectomy and ileorectal anastomosis for Crohn's colitis. Dis Colon Rectum 2011; 54: 1347-54.
25. Buchmann P, Keighley MR, Allan RN et al. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg 1980; 140: 642-4.
26. Fry RD, Shemesh EI, Kodner IJ et al. Techniques and results in the management of anal and perianal Crohn's disease. Surg Gynecol Obst 1989; 168: 42-8.
27. Bell SJ, Williams AB, Wiesel P et al. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther 2003; 17: 1145-51.
28. Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg 2000; 24: 1258-62; discussion 1262-3.
29. Hong MK. Craig Lynch A, Bell S et al. Faecal diversion in the management of perianal Crohn's disease. Colorectal Dis 2011; 13: 171-6.